Ignite Creation Date:
2024-05-06 @ 9:56 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03112733
Status:
UNKNOWN
Last Update Posted:
2019-02-26
First Post:
2017-04-04
Brief Title:
Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers
Sponsor:
Ilker Kahramanoglu
Organization:
Istanbul University
Study Overview
Official Title:
Value of TFF3 SFRP4 Romo1 and NFKB as Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers
Status:
UNKNOWN
Status Verified Date:
2019-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the usefulness of serum levels of trefoil factor 3 TFF3 secreted frizzled related protein 4 sFRP-4 reactive oxygen species modulator 1 Romo1 and nuclear factor NF-κB as potential diagnostic and prognostic biomarkers in ovarian carcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| TAB-2017-22506 | OTHER_GRANT | Istanbul University Scientific Research Projects | None |